L-Carnitine Market is expected to reach US$ 262.6 Mn in 2027

Published Date: 22 Apr 2020

Report : L-Carnitine Market to 2027 - Global Analysis and Forecasts by Process (Chemical Synthesis, Bio-process); Product (Food, Pharmaceutical Grade, Feed Grade); Application (Animal Feed, Healthcare Products, Functional Drinks, Medicines)

Growing demand for L-Carnitine supplements to enable efficient conversion of food into energyis expected to escalate the global L Carnitine market at a CAGR of 4.8%

 

According to the latest study on “Global L Carnitine Market to 2027 – Analysis and Forecast by Process (Chemical Synthesis, Bio-process); Product (Food, Pharmaceutical Grade, Feed Grade); Application (Animal Feed, Healthcare Products, Functional Drinks, Medicines), and Geography”. L-Carnitine is a naturally occurring compound in the bodies of humans and animals which playsan  important role of shuttling fatty acids to and fro in the cells to produce energy. It is produced in the liver and kidneys. However, certain individuals are unable to produce or synthesize required amount of L-Carnitine owing to genetic conditions or defects. Individuals unable to synthesize L-Carnitine suffer from primary and secondary carnitine deficiency. The US Food and Drug Administration (FDA) has approved the use of oral and intravenous (IV) L-Carnitine for treating primary and secondary carnitine deficiency. At present, L-Carnitine is commercially advertised as nutritional supplements to enhance exercise performance and promote weight loss. It is also approved to be used in the treatment of carnitine deficiencies in patients at the end stage of renal diseases undergoing hemodialysis. Besides its uses in human nutrition, L-Carnitine is also used as an additive in the formulation of animal feed formulations. It is used in the poultry industry to increase egg production and improve egg hatchability.

 

The global L Carnitine market was valued at US$ 172.2 Mn in 2018 and is projected to reach US$ 262.6 Mnby 2027; it is expected to grow at a CAGR of 4.8% during 2019–2027. The report includes key understanding on the driving factors of this growth and also highlights the prominent players in the market and their developments.

 

L-Carnitine has been recommended by medical professionals globally to individuals with genetic disorders whose bodies are unable to naturally synthesize carnitine. L-Carnitine plays a major role in keeping up with the requirements of energy production in the body, as it is involved in transporting long-chain fatty acids to the mitochondria for energy production. The US Food and Drug Administration has approved the use of (IV) L-Carnitine for treating primary and secondary carnitine deficiencies. L-Carnitine supplements are also used to treat carnitine deficiencies resulting from poor carnitine absorption and chronic kidney failure. Moreover, the widespread use of carnitine in treating carnitine deficiency in end-stage renal diseases resulting from dialysis has compounded the consumption of L-Carnitine in the form of supplements. The use of L-Carnitine in the form of supplements to cure involuntary weight loss and increase the body mass index (BMI) in patients with cachexia or wasting syndrome has steadily risen. Rising consumption of L-Carnitine to improve lean body mass in people with wasting syndrome is expected to further boost the growth of the L-Carnitine market. The L Carnitine market in APAC is expected to grow at the highest CAGR during the forecast period.Factors such as growing demand for nutritional supplements coupled with increasing use in the personal and sports nutrition product are driving its demand in APAC. Functional food and beverages have gained immense popularity among the health-conscious population that has made an impact on the demand for L carnitine in the region.

                               

ALPSURE LIFESCIENCES PVT. LTD, Biosint S.p.A., Cayman Chemical, Cheng Da PharmaCeuticals Co., Ltd, Huang Gang Hua Yang Pharmaceutical Co., Ltd, Kaiyuan Hengtai Nutrition Co., Ltd., Lonza Group Ltd, Maxsun Industries Incorporated, Merck KGaA, and Northeast Pharmaceutical Group Co., Ltd, are among the key players present in the global L Carnitine market.

Global L Carnitine Market Breakdown- by Region, 2018

Global L Carnitine Market Breakdown- by Region, 2018

The report segments the global L-Carnitine market as follows:

 

L-Carnitine Market - By Process

  • Chemical Synthesis
  • Bio-process

L-Carnitine Market - By Product

  • Food
  • Pharmaceutical Grade
  • Feed Grade

L-Carnitine Market - By Application

  • Animal Feed
  • Healthcare Products
  • Functional Drinks
  • Medicines

 

L-Carnitine Market - By Geography

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • France
    • Italy
    • Spain
    • Rest of Europe
  • Asia Pacific (APAC)
    • China
    • Australia
    • India
    • Japan
    • South Korea
    • Rest of Asia Pacific
  • Middle East and Africa (MEA)
    • Download PDF Brochure